That doesn't sound at all to me like a company investing in an emerging biotechs with developing fundamentals, but rather a focused biotech venture capital entity, perhaps like Shire, PLC.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.